HHTM

Signia, and its predecessor Siemens, has an impressive legacy of innovation geared toward enhancing the real-world performance of individuals with hearing loss. In this episode of This Week in Hearing, Bob and Brian recap many of the key milestones in the history of hearing aid technology over the past 75 years. In addition to their conversation, there were some important

Dear Readers: During this holiday season, the editors at Hearing Health & Technology Matters (HHTM) are taking some time off. However, we are not leaving you without anything to read on our blog this week. Instead, we are publishing a special holiday edition filled with what we call our Readers’ Choice. Our Readers’ Choices featured this week are the posts

Last week, GN Hearing announced the acquisition of New York based Lively – a leading online direct-to-consumer hearing care retailer for approximately $95 million dollars. GN Hearing CEO, Gitte Aabo, returns to This Week in Hearing to discuss the motivation behind the acquisition with Bob Traynor. The pair discuss how the move strengthens GN’s position to better meet the needs

Hearing aids have never been so sophisticated, yet uptake and consistent daily use often lag behind technological innovation. In this episode of This Week in Hearing Bec Bennett, PhD, researcher at the Ear Science Institute in Perth Australia sits down with Brian Taylor to discuss her research on under-reported hearing aid problems and how they can be handled by clinicians.   Be sure

In this week’s technology spotlight, Dr. Bob Traynor speaks with Robert Koch, the President and Founder of hearing healthcare startup, AHead Simulations. Koch’s company has developed and commercialized CARL, a simulator used widely in audiology training programs across the US and Canada. The pair discuss how simulators, like CARL, can help enhance and improve the clinical training process and how

Age-related hearing loss is a common problem in adults and it might be starting earlier than we think. Courtney Coburn Glavin, a PhD candidate, at Northwestern University sits down with Brian Taylor to review her research using DPOAEs to identify hearing loss of early onset in young adults and the clinical implications of her work. They also discuss the limitations

I was recently prescribed a new medication by my doctor but before I began taking it, I wanted to understand if it could harm my hearing. I already have a moderate progressive hearing loss, so I do everything I can to protect the hearing I still have.  “I have hearing loss so am wondering if this drug is ototoxic?” I

This Week in Hearing co-hosts, Dave Kemp, Bob Traynor, Amyn Amlani, and Brian Taylor, reflect on insights they’ve gained and key takeaways they’ve learned from more than 25 interviews with industry experts on the latest developments in the hearing industry. The lively discussion centers around the evolving landscape of hearing health – from hearing care delivery, to regulations, changing technology

This special edition of This Week in Hearing offers a candid discussion on the health care landscape, as provided by two accomplished and distinguished physicians: Dr. Ardeshir Z. Hashmi, Endowed Chair of Geriatric Innovation and Section Chief of the Center for Geriatric Medicine at Cleveland Clinic, and Dr. Fred Ma, Chief Medical Officer and Senior Vice President at Cognivue, Inc.

The role of cognitive screenings in audiology practice has been and continues to be a topic of discussion. In this special edition of This Week in Hearing, HHTM is partnering with the Academy of Doctors of Audiology to bring our viewers a recording of the Panel Session entitled, “Understanding the Relationship between Cognitive Decline and Hearing Loss,” that occurred during